South African president calls on WHO for better mpox response
Amidst the global health emergency declared for mpox, the South African president has called for a greater emphasis on an…
Infectious Disease
-
-
AN2 slashes staff by 50% after lead antibiotic flunks in Phase II/III trial
AN2 Therapeutics has implemented cost-saving measures after “disappointing” topline results from Phase II part of the Phase II/III trial evaluating…
-
Valneva and LimmaTech partner for shigellosis vaccine development
Valneva and LimmaTech Biologics have signed a strategic partnership to further the development of Shigella4V (S4V), a tetravalent bioconjugate vaccine…
-
SII and Oxford University’s malaria vax launched in Côte d’Ivoire
The R21/Matrix-M malaria vaccine, co-developed by the Serum Institute of India (SII) and the University of Oxford, has been launched…
-
AusperBio secures funding to advance AHB-137 for CHB
AusperBio has raised $37m in a Series A financing round to propel the clinical development of AHB-1 for chronic hepatitis…
-
BARDA and Tiba Biotech link to develop ‘flu therapeutics
Tiba Biotech, a US preclinical biopharmaceutical company based in Cambridge, Massachusetts, has announced a partnership with the Biomedical Advanced Research…
-
Emergent scores US medical countermeasure contracts worth over $250m
Emergent BioSolutions has received contract modifications worth more than $250m from the US Department of Health and Human Services (HHS)…
-
UK’s new Netflix-style funding model for antibiotics goes live
Antimicrobial resistance (AMR) is one of the biggest challenges facing healthcare systems across the globe today, with the problem expected…
-
ESCMID 2024: Using AI in infection prevention and control
At the 34th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global (formerly ECCMID) conference in Barcelona, Spain, the…
-
Q&A: BARDA wants to back tech that can combat multiple infections, says director
Following the rapid development and commercialisation of Covid-19 vaccines and therapeutics, multiple pharmaceutical companies such as AstraZeneca, Moderna, and Pfizer…
